Psoriasis News

Healio has compiled July’s most-read news in dermatology.

The American Skin Association has announced the recipients of its 2024 research grants for skin cancer and diseases, according to a press release.

Arcutis has submitted a supplemental new drug application for Zoryve foam 0.3% for the treatment of scalp and body psoriasis in adults and adolescents aged 12 years and older, according to a company press release.

Patients with psoriasis, specifically those with a high BMI, had lower concentrations of polyunsaturated fatty acids and elevated concentrations of saturated fatty acid, which correlate to greater disease severity, according to a study.

While the art of tattooing has been present for centuries, the medical implications are only recently coming to light with modern medicine.

A higher risk for developing psoriasis was found in subjects who were fed formula as infants compared with those who were breastfed for at least the first 4 months of life, according to a Swedish study.

Patients with psoriasis treated with higher doses of oral zasocitinib experienced greater improvement than those treated with placebo, according to a phase 2b study.

Healio has compiled June’s most-read news in dermatology.

Makeup not only has cosmetic applications, but medical ones too.

Ilumetri effectively restored the level of well-being of patients with moderate to severe plaque psoriasis to those of the general population, according to interim results released by Almirall.